Six Tech Trends That Will Shape the Pharmaceutical Industry in 2013 #emcure #pharma

Posted On Oct 23 2016 by

#pharmaceutical industry overview 2013 # Six Tech Trends That Will Shape the Pharmaceutical Industry in 2013 Life sciences companies face unprecedented challenges as revenues come under pressure as a consequence of pricing pressures caused by healthcare reforms and austerity measures, increased competition, and challenges in bringing new drugs and other products to market. They are responding by focusing on growth opportunities in emerging markets, pursuing breakthrough innovation through collaboration with industry and academic partners, challenging and revolutionizing the traditional sales, marketing and research and development (R D) operating models and focusing on operational efficiency. Shifts in the behavior of patients …


Pharmaceutical Industry Outlook 2013, Life Sciences Industry Outlook 2013 #pharmaceutical #manufacture

Posted On Oct 23 2016 by

#pharmaceutical industry overview 2013 # Biopharma Life Sciences Outlook 2013 What are the Biggest Challenges and Opportunities Facing the Biopharma Life Sciences Industry During the Next Year? Pharma executives need to carefully consider their approach as they work to improve health economics and patient outcomes. To address unyielding pricing pressures and the enhanced requirement for clinical innovation, pharma companies should calibrate their drug development life cycle to select drug candidates early in the life cycle based on efficacy and economics, provide the evidence for approval and favorable reimbursements, and maintain a strong market position through post-launch evidence. This is especially …


Pharmaceutical information #drug #manufacturer

Posted On Oct 23 2016 by

#pharmaceutical information # Erelzi Erelzi (etanercept-szzs) is a tumor necrosis factor (TNF) blocker biosimilar to Enbrel indicated for the treatment of rheumatoid arthritis. Troxyca ER Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) is an extended-release, abuse-deterrent, narcotic analgesic formulation. Sustol Sustol (granisetron) is a long-acting 5-HT3 antagonist indicated for the prevention of chemotherapy-induced nausea and vomiting (CINV). Drugs in Development (Not yet approved) Ingrezza Ingrezza (valbenazine) is a novel, highly-selective VMAT2 inhibitor in development for the treatment of tardive dyskinesia. brigatinib Brigatinib is an investigational anaplastic lymphoma kinase (ALK) inhibitor in development for the treatment of patients with anaplastic. Radicava …


Indian Pharmaceutical Industry: Latest News – Videos, Photos about Indian Pharmaceutical Industry #sandoz #pharma

Posted On Oct 23 2016 by

#pharma industry news # INDIAN PHARMACEUTICAL INDUSTRY Buy Sun Pharmaceutical Industries, target Rs 890: Swati Hotkar Buy Sun Pharmaceutical Industries Ltd. at a price target of Rs 890 and a stop loss at Rs 830 4 Aug, 2016, 12.12PM IST Buy Sun Pharmaceutical Industries Ltd. target Rs 947.0. Reliance Securities Buy Sun Pharmaceutical Industries Ltd. at a price target of Rs 947.0 and a stop loss at Rs $stopLossL from entry point 19 Aug, 2016, 01.25PM IST Buy Sun Pharmaceutical Industries Ltd. target Rs 880.0. Reliance Securities Buy Sun Pharmaceutical Industries Ltd. at a price target of Rs 880.0 and …


Ex-KV Pharmaceutical CEO Pleads Guilty, Gets 30-Day Sentence #pharmaceutical #companies #usa

Posted On Oct 23 2016 by

#kv pharma # Ex-KV Pharmaceutical CEO Pleads Guilty, Gets 30-Day Sentence Marc Hermelin, the former KV Pharmaceutical Co. chief executive officer banned last year from doing business with the U.S. pleaded guilty to violating drug-labeling laws and was sentenced to 30 days in prison. U.S. District Judge E. Richard Webber in St. Louis also ordered Hermelin today to pay a $1 million fine and forfeit $900,000. Hermelin, who the Bridgeton, Missouri-based company said was fired as CEO and chairman in 2008 and who resigned as a director in November, reached a plea agreement today with prosecutors, who also announced the …


Chicago pharmaceutical companies #pharma #conference

Posted On Oct 23 2016 by

#chicago pharmaceutical companies # Together we’re taking on tough health challenges. See what we are working on. YOU ARE ABOUT TO LEAVE FOR A 3RD PARTY WEBSITE The “Yes” link below will take you out of the AbbVie family of websites. Links which take you out of the AbbVie worldwide websites are not under the control of AbbVie, and AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the …


Top 10 Pharmaceutical Companies in India #pharma #digital #marketing

Posted On Oct 23 2016 by

#list of pharma companies # Pharmaceutical Companies in India Pharmaceutical Industry in India India is the world’s third largest pharmaceutical industry in terms of volume and world’s 13th largest pharmaceutical industry by value. The top 8 to 10 companies including Sun Pharma, Lupin, Dr. Reddy’s Labs and Cipla occupy 70 to 80 percent of the Indian pharmaceutical market space. It is estimated by a Fitch Group company named India Rating that the Indian pharmaceutical industry will grow at a rate of 20 percent during 2015-2020. The domestic market is expected to do better this time as the projected growth rate …


European Pharmaceutical Review #pharma.org

Posted On Oct 23 2016 by

#pharmaceutical manufacturing magazine # European Pharmaceutical Review Issues Supplements Secure your copy With every subscription, you ll get access to all past and future copies of European Pharmaceutical Review. as well as all of our exclusive online content, including the latest news, articles, webinars, videos, whitepapers, application notes, and much more! So, what are you waiting for? Advertise in this issue Want to find out about advertising opportunities in this issue? Contact us now Issue #4 2016 Here s a summary of what you ll find in the next issue of European Pharmaceutical Review: ENVIRONMENTAL MONITORING IN-DEPTH FOCUS Bacterial endotoxin …


Pharmaceutical Manufacturing Magazine Article: “Critical Success Factors in Raw Material Storage – Conveyance” #bayer #pharma

Posted On Oct 23 2016 by

#pharmaceutical manufacturing magazine # Pharmaceutical Manufacturing Magazine Article: “Critical Success Factors in Raw Material Storage Conveyance” Mark Hoffman, PE, PMP, Department Manager in Food and Consumer Products at SSOE Group, was recently published in Pharmaceutical Manufacturing Magazine. Hoffman has over 30 years of experience in project and engineering management in the pharmaceutical processing, food processing, nutraceutical processing, bio-processing, renewable energy. ammonia refrigeration, and food ingredient industries. In his article, he explains how a consistently dependable environment for raw material storage and conveyance is imperative to practical and profitable production flow in pharmaceutical manufacturing . Every manufacturing facility is unique, with …


Pharmaceutical Conferences #pharma #test

Posted On Oct 23 2016 by

#pharma conference # Welcome to The Pharmaceutical Conferences Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business. Explore and learn more about Conference Series LLC. World’s leading Event Organizer Conference Series LLC through its open access initiative hosts over highly valued 700 leading-edge peer reviewed Open Access Journals and organizes over 1000+ Global Events annually all over the world. Conference Series LLC Journals have around 100000 Editorial and reviewers ensures the quality and fast editorial, review processing with time of publishing …